Skip to main content

Properties of a recombinant yeast-derived hepatitis B surface antigen containing S, preS2 and preSl antigenic domains

  • Conference paper
Chronically Evolving Viral Hepatitis

Part of the book series: Archives of Virology ((ARCHIVES SUPPL,volume 4))

Summary

Yeast cells have been engineered to express mixed HBsAg particles containing the S and a modified large (L*) protein. Their construc¬tion resulted in reduced protease sensitivity, reduced glycosylation and complete inactivation of the polymerized human albumin binding site. The particles exposed the S, preSl and preS2 antigenic determinants and induced an immune response against the three domains. Highly purified preparations have been obtained and are presently being tested in human volunteers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alberti A, Pontisso P (1987) Antibody to preS antigens in hepatitis B virus infection. Hepatology 7: 207–208

    Article  PubMed  CAS  Google Scholar 

  2. André FE, Safary A (1988) Clinical experience with a yeast-derived hepatitis B vaccine. In: Zuckerman AJ (ed) Viral hepatitis and liver disease. Liss, New York, pp 1025–1030

    Google Scholar 

  3. Barnaba V, Franco A, Alberti A, Benvenuto R, Balsano F (1990) Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes. Nature 345: 258–260

    Article  PubMed  CAS  Google Scholar 

  4. Ferrari C, Penna A, Bertoletti A, Cavalli A, Valli A, Schianchi C, Fiaccadori F (1989) The preSl antigen of hepatitis B virus is highly immunogenic at the T cell level in man. J Clin Invest 84: 1314–1319

    Article  PubMed  CAS  Google Scholar 

  5. Gerety RJ (1988) Recombinant hepatitis B vaccines. In: Zuckerman AJ (ed) Viral hepatitis and liver disease. Liss, New York, pp 1017–1024

    Google Scholar 

  6. Harford N, Cabezon T, Crabeel M, Simoen E, Rutgers A, De Wilde M (1983) Expression of hepatitis B surface antigen in yeast. Dev Biol Stand 54: 125–130

    PubMed  CAS  Google Scholar 

  7. Heermann KH, Goldmann V, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH

    Google Scholar 

  8. Large surface proteins of hepatitis B virus containing the preS sequence. J Virol 52: 396–402

    Google Scholar 

  9. Hellström U, Sylvan S (1986) Human serum albumin and the enigma of chronic hepatitis type B. Scand J Immunol 23: 523–527

    Article  PubMed  Google Scholar 

  10. Iwarson S, Tabor E, Thomas HC, Goodall A, Waters J, Snoy P, Shih JWK, Gerety RJ

    Google Scholar 

  11. Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody. An experimental study in chimpanzee. J Med Virol 16: 89–96

    Google Scholar 

  12. Milich DR, Mc Lachlan A, Chisari FV, Kent BH, Thornton GB (1986) Immune response to the pre-S(l) region of the hepatitis B surface antigen (HBsAg): a pre-S(l) specific T cell response can bypass non responsiveness to the pre-S(2) and S regions of HBsAg. J Immunol 137: 315–322

    PubMed  CAS  Google Scholar 

  13. Milich DR, Mc Namara MK, Mc Lachlan A, Thornton GB, Chisari FV (1985) Distinct H-2 linked regulation of T-cell responses to pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of non responsiveness to the S region. Proc Natl Acad Sci USA 82: 8168–8172

    Article  PubMed  CAS  Google Scholar 

  14. Neurath AR, Seto B, Strick N (1989) Antibodies to synthetic peptides from the preSl region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine 7: 234–236

    Article  PubMed  CAS  Google Scholar 

  15. Petit M-A, Dubanchet S, Capel F (1989) A monoclonal antibody specific for the hepatocyte receptor binding site on hepatitis B virus. Mol Immunol 26: 531–537

    Article  PubMed  CAS  Google Scholar 

  16. Waters J, Pignatelli M, Galpin S, Ishihara K, Thomas HC (1986) Virus neutralizing antibodies to hepatitis B: the nature of an immunogenic epitope on the S gene peptide. J Gen Virol 67: 2467–2473

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag

About this paper

Cite this paper

Petre, J., Rutgers, T., Hauser, P. (1992). Properties of a recombinant yeast-derived hepatitis B surface antigen containing S, preS2 and preSl antigenic domains. In: De Bac, C., Taliani, G., Gerlich, W.H. (eds) Chronically Evolving Viral Hepatitis. Archives of Virology, vol 4. Springer, Vienna. https://doi.org/10.1007/978-3-7091-5633-9_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-5633-9_30

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82350-7

  • Online ISBN: 978-3-7091-5633-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics